HOME

Day One

Morning Plenary Sessions:
MNC Strategies for New Drug R&D in China
Afternoon Sessions:
Track A:Biotech investment
Track B:Oncology Trials
8:30-17:30, Nov 28th

Day Two

Track A:
Preclinical and Drug Discovery Technologies
Track B:
Clinical Trial Partnering
08:50-16:30, Nov 29th

>>Add into Calendar

Asia Pharma R&D Leaders 2012


Asia Pharma R&D Leaders 2012 is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CROs, SMOs, academic institutions, investors and all the way down to other industrial stakeholders to assess the latest industrial trends, R&D strategies, partnership models and technology advancements in China and Asia.

This is the largest annual pharmaceutical R&D gathering in China featuring multiple conferences, summits and seminars that cover the entire value chain of the pharma R&D. Asia Pharma R&D Leaders 2012 will show you how you can access the important markets in Asia that matters most to your R&D strategies. Our aim is to promote global and regional deal making between pharmas, biotechs and academics in China and across other Asian countries and to leverage technologies to your advantage in promising drug discovery, screening, safety, clinical trials and R&D activities in the region.

Key Issuesㄩ
  • Conference 每300+ executive level attendees from 15 countries and regions working within R&D strategy, Partnering, Clinical Trials, Discovery and Preclinical etc
  • Technology 每 from Multi Omics, Screening, Microplate Readers all the ways to sequencer and EDC etc on showcase
  • Seminars 每 40+ eminent speakers with 60 seminars featuring technical and strategic topics
  • Posters - 100 posters from leading research institutes on showcase
  • Top Life Science VC/PE 每 30+ Asian and global life science VC/PE looking for investment opportunities in China
  • One on One Partnering Meetings 每60 prescheduled one to one business meetings
Speakers
Xielong Luo
Vice President
Chinese Pharmaceutical Enterprise Association


Jennifer Hu
VP & Head of Innovation Center, China
Bayer


Jun Bao
Director of Worldwide Business Development
GSK


Baoping Wang
President and Head of NNST
Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd (NNST)


Zaiqi Wang
Executive Director Clinical Research
MSD


Jimmy Z. Zhang
Greater China Lead, Licensing, Acquisitions & External Research
Merck & Co.


Helen Niu
Head of Global Clinical Development
Allergan China


Zhengping Wu
Senior Vice President,Pharmaceutical Sciences
Hutchison Medi Pharma


Gene Hsu
VP,CSO
Shanghai InnoStar Bio-Tech Co., Ltd.


Jiping Zha
VP, Drug Discovery Technology
Crown Bioscience


Sam Lou
MBA, VP Business Development in Greater China,
Crown BioScience, Inc.


Cao Guoqing
VP of Biology
Jiangsu Hengrui Medicine


Lee Geiger
Safety Assessment
GlaxoSmithKline


Xiaochun Xu
Founder INCOSC, Chairman & CEO, BoyaLife Group Co,
Institute of Molecular Medicine, Peking University


James Huang
Managing Partner
KPCB, China


William Hu
Healthcare Partner
Qiming Ventures


Dianna Qian
Principal
Fidelity Growth Partners Asia


Jeremy Teo
Associate Principal
McKinsey & Company*s Shanghai Office


Yunling Ren
Partner
King& Wood Mallesons


Michael Davitz
Partner
Axinn Veltrop & Harkrider LLP


Songkai Liu
Sr. Pharma Business Manager, Asia Pacific
QIAGEN


Yingli Wang
Associate (Shanghai Office Representative)
Perkins Coie LLP


Fenlai Tan
Vice President
Beta Pharma


Sophia Qian
Managing Director
Life Science Park in Xuhui Fenglin


Helen Jiang
Executive Director
Clinical Research of Jiangsu Hengrui Medicine


Anfan Wu
Head, Early Development
Roche R&D Center (China) Ltd.


Yi Shi
Managing Director
Lilly Asia Ventures


Who Should Attend?
Chief Executives, Vice President, Scientists, Directors, General Managers and:
  • Head of R&D
  • Head of Clinical R&D
  • Medical Directors
  • Head of Clinical Development
  • Head of Preclinical Development
  • Head of Regulatory Affairs
  • Head of Biostatistics
  • Head of Safety Assessment
  • Head of Clinical Operations
  • Head of Pharmacovigilance
  • Head of Clinical Risk Management
  • Head of Exploratory Development
  • Head of Biometric
  • Head of Study Feasibility and
  • Patient Enrolment
  • Head of clinical data management
  • Head of Medical Affairs
  • Head of Project Management
  • Head of Global Research
  • Head of Drug Discovery
  • Chief Scientific Officer
  • Principal Scientist
  • Principle Clinical Investigator
  • Chief Technology Officer
  • Head of Translational Research
  • Head of Toxicology
  • Head of Stemcell Research
  • Head of Modelling & Simulation
  • Head of Exploratory Development
  • Head of Chemistry
    Attendee From Following Companiesㄩ
  • Big Pharma
  • Biotechs
  • CROs
  • Academics and Research Institutes
  • Technology Providers
  • Venture Capitalists
  • Research equipment providers
  • Consulting
Media Partners
  •     
  •     
  •     
  •     
  •     
  •     
  •     
  •     

 

For more information, please contact Sky Zhong by +86 21 5242 8136 or Email to Sky zhong@shinemediaworld.com